All Pharma News
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split

Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
GLOBENEWSWIRE
01 Jun 2023
Share Share
Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica

Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica
BIOSPACE
17 Jan 2023
Share Share
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement

Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
GLOBENEWSWIRE
17 Jan 2023
Share Share
Cancer vaccine developer jumps to Nasdaq via reverse merger

Cancer vaccine developer jumps to Nasdaq via reverse merger
Amber Tong ENDPTS
17 Jan 2023
Share Share
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GLOBENEWSWIRE
21 Dec 2022
Share Share
Angion Reports Second Quarter 2022 Financial Results

Angion Reports Second Quarter 2022 Financial Results
GLOBENEWSWIRE
15 Aug 2022
Share Share
Angion hangs up `for sale` sign, stops drug development work

Angion hangs up `for sale` sign, stops drug development work
Nick Paul Taylor FIERCEBIOTECH
27 Jul 2022
Share Share
Angion Announces Process to Explore Strategic Alternatives for Shareholder Value

Angion Announces Process to Explore Strategic Alternatives for Shareholder Value
GLOBENEWSWIRE
25 Jul 2022
Share Share
Anguish for Angion as safety signal sinks kidney disease trial

Anguish for Angion as safety signal sinks kidney disease trial
Nick Paul Taylor FIERCEBIOTECH
30 Jun 2022
Share Share
Angion Announces Discontinuation of PII Trial of ANG-3070 in PPKD

Angion Announces Discontinuation of PII Trial of ANG-3070 in PPKD
GLOBENEWSWIRE
29 Jun 2022
Share Share